Results 271 to 280 of about 214,320 (304)

C1 inhibitor

2006
openaire   +1 more source

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Lancet, The, 2010
Uri Lopatin, William D Bradford, Edward Gane   +2 more
exaly  

Acquired C1 Esterase Inhibitor Deficiency

Annals of Internal Medicine, 2000
T, Caballero, M, Concepcion Lopez-Serrano, M, Lopez-Trascasa   +2 more
openaire   +4 more sources

C1 Inhibitor

2008
openaire   +1 more source

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Lancet, The, 2011
Klemens Budde, Claudia Sommerer, Petra Reinke   +2 more
exaly  

C1 INHIBITOR IN MALIGNANT DISEASES

The Lancet, 1976
P J, Lachmann, J, Wragge-Morley
openaire   +2 more sources

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Lancet, The, 2010
Michael Friedlander, Clare L Scott, Jeffrey N Weitzel   +2 more
exaly  

C1 inhibitor

2011
openaire   +1 more source

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Lancet, The, 2013
Marina Cuchel, Dirk J Blom, A David Marais   +2 more
exaly  

C1-inhibitor

2009
openaire   +1 more source